Cargando…
Debridement, antibiotics, and implant retention in non-oncological femoral megaprosthesis infections: minimum 5 year follow-up
PURPOSE: Megaprostheses are increasingly utilised outside of the oncological setting, and remain at significant risk of periprosthetic joint infection (PJI). Debridement, antibiotic, and implant retention (DAIR) is an established treatment for PJI, however its use in non-oncological patients with fe...
Autores principales: | Asokan, A., Ibrahim, M. S., Thompson, J. W., Haddad, F. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001793/ https://www.ncbi.nlm.nih.gov/pubmed/35403987 http://dx.doi.org/10.1186/s40634-022-00469-9 |
Ejemplares similares
-
The Potential Innovative Use of Bacteriophages Within the DAC(®) Hydrogel to Treat Patients With Knee Megaprosthesis Infection Requiring “Debridement Antibiotics and Implant Retention” and Soft Tissue Coverage as Salvage Therapy
por: Ferry, Tristan, et al.
Publicado: (2020) -
Debridement, Antibiotics, and Implant Retention for Acute Periprosthetic Joint Infection
por: Zhang, Chao‐fan, et al.
Publicado: (2020) -
Silver-Coated Hip Megaprosthesis in Oncological Limb Savage Surgery
por: Donati, F., et al.
Publicado: (2016) -
Megaprosthesis in Non-Oncologic Settings—A Systematic Review of the Literature
por: Sambri, Andrea, et al.
Publicado: (2023) -
Principles of mechanical and chemical debridement with implant retention
por: Deckey, David G., et al.
Publicado: (2023)